Academia.eduAcademia.edu

Outline

Title
Abstract
References
All Topics
Biology
Biochemistry

The Role of Leucine in Weight Loss Diets and Glucose Homeostasis

Profile image of Donald LaymanDonald Layman

2003, Journal of Nutrition

https://doi.org/10.1093/JN/133.1.261S
visibility

…

description

7 pages

link

1 file

Abstract

Debate about the optimum balance of macronutrients for adult weight maintenance or weight loss continues to expand. Often this debate centers on the relative merits or risks of carbohydrates vs. fats; however, there is increasing interest in the optimal level of dietary protein for weight loss. Diets with a reduced ratio of carbohydrates/protein are reported to be beneficial for weight loss, although diet studies appear to lack a fundamental hypothesis to support higher protein intakes. Presently, needs for dietary proteins are established by the recommended daily allowance (RDA) as the minimum level of protein necessary to maintain nitrogen balance. The RDA define the primary use of amino acids as substrates for synthesis of body proteins. There is emerging evidence that additional metabolic roles for some amino acids require plasma and intracellular levels above minimum needs for protein synthesis. The branched-chain amino acid leucine is an example of an amino acid with numerous metabolic roles that function in proportion with cellular concentration. This review provides an overview of the current understanding of metabolic roles of leucine and proposes a metabolic framework to evaluate the merits of a higher protein diet for weight loss.

Related papers

Dietary l-leucine and l-alanine supplementation have similar acute effects in the prevention of high-fat diet-induced obesity
Susanne Klaus

Amino Acids, 2013

High-protein diets have been shown to alleviate detrimental effects of high-fat diets and this effect can be partially mimicked by dietary L-leucine supplementation. Here, we aimed to elucidate the early mechanisms and the specificity of leucine effects. We performed a 1-week trial with male C57BL/6 mice fed ad libitum with semisynthetic high-fat diets containing an adequate (10 % w/w, AP) or high (50 % w/w, HP) amount of whey protein, or supplemented with L-leucine corresponding to the leucine content within the HP diet (Leu) or supplemented with equimolar L-alanine (Ala). Food and water intake were monitored continuously using a computer-controlled monitor system and body composition changes were assessed using quantitative NMR. HP completely prevented the AP-induced accumulation of body fat. Leu and Ala resulted in a similar reduction of body fat accumulation which was intermediate between AP and HP. There were no significant effects on plasma glucose or insulin. Triacylglycerol content and gene expression of lipogenesis enzymes in liver as well as plasma cholesterol were reduced by HP compared to AP with Leu and Ala again showing intermediate effects. Body fat gain and liver triacylglycerols were strongly correlated with total energy intake. Water intake was rapidly increased by HP feeding and total water intake correlated strongly with total amino nitrogen intake. We concluded that the positive effects of high-protein diets on metabolic syndrome associated traits are acutely due to effects on satiety possibly linked to amino nitrogen intake and on the subsequent suppression of liver lipogenesis without evidence for a specific leucine effect. Keywords High-protein diet Á L-Leucine supplementation Á L-Alanine supplementation Á Satiety Á Energy intake Á Water intake Á Metabolic syndrome Á Diet-induced fatty liver This study was presented in part at Experimental Biology 2012, April 21-25, San Diego, CA, USA (Petzke et al. 2012).

View PDFchevron_right
Review Beyond the Role of Dietary Protein and Amino Acids in the Prevention of Diet-Induced Obesity
Susanne Klaus

2014

Abstract: High-protein diets have been shown to prevent the development of diet-induced obesity and can improve associated metabolic disorders in mice. Dietary leucine supplementation can partially mimic this effect. However, the molecular mechanisms triggering these preventive effects remain to be satisfactorily explained. Here we review studies showing a connection between high protein or total amino nitrogen intake and obligatory water intake. High amino nitrogen intake may possibly lower lipid storage, and prevent insulin resistance. Suggestions are made for further systematical studies to explore the relationship between water consumption, satiety, and energy expenditure. Moreover, these examinations should better distinguish between leucine-specific and unspecific effects. Research in this field can provide important information to justify dietary recommendations and strategies in promoting long-term weight loss and may help to reduce health problems associated with the comorb...

View PDFchevron_right
Leucine supplementation modulates fuel substrates utilization and glucose metabolism in previously obese mice
Thierry Leste-Lasserre

Obesity, 2013

Objective: High-protein diets favor weight loss and its maintenance. Whether these effects might be recapitulated by certain amino acids is unknown. Therefore, the impact of leucine supplementation on energy balance and associated metabolic changes in diet-induced obese (DIO) mice during and after weight loss was investigated. Methods: DIO C57BL/6J mice were fed a normocaloric diet to induce weight loss while receiving or not the amino acid leucine in drinking water. Body weight, food intake, body composition, energy expenditure, glucose tolerance, insulin, and leptin sensitivity were evaluated. Q-PCR analysis was performed on muscle, brown and white adipose tissues. Results: DIO mice decreased body weight and fat mass in response to chow, but supplementation with leucine did not affect these parameters. During weight maintenance, mice supplemented with leucine had improved glucose tolerance, increased leptin sensitivity, and lower respiratory quotient. The latter was associated with changes in the expression of several genes modulating fatty acid metabolism and mitochondrial activity in the epididymal white and the brown adipose tissues, but not muscle. Conclusions: Leucine supplementation might represent an adjuvant beneficial nutritional therapy during weight loss and maintenance, because it improves lipid and glucose metabolism and restores leptin sensitivity in previously obese animals.

View PDFchevron_right
Effects of leucine supplementation on the body composition and protein status of rats submitted to food restriction
Jose Donato, Julio toledo

Nutrition (Burbank, Los Angeles County, Calif.), 2006

Acute administration of leucine has been shown to stimulate certain protein synthesis related anabolic processes. However, the effect of chronic leucine administration in a catabolic situation caused by food restriction (FR) has not been established. We therefore evaluated the effect of chronic leucine supplementation on the body composition and some indicators of protein nutritional status of rats submitted to FR. Adult male Wistar rats were submitted to 50% FR for 6 weeks. The control group received the AIN-93M diet and the leucine group received the same diet supplemented with 5.91 g L-leucine/kg ration. We then determined carcass chemical composition, serum leptin, albumin and total protein concentrations, and protein, DNA and RNA concentrations in gastrocnemius muscle and liver. No difference in final body weight was observed between groups. However, the leucine group presented a lower amount of body fat (P < 0.05). Leptin concentration showed a directly proportional correla...

View PDFchevron_right
Modulation of leucine oxidation and turnover by graded amounts of carbohydrate intake in obese subjects
Emile Morse

Metabolism-clinical and Experimental, 1982

Our previous in vitro studies with rat tissues have suggested that ketone bodies may regulate the oxidation of branched-chain amino acids. To investigate the physiological and clinical significance of this observation, we determined the effect of starvation-induced ketosis on leucine metabolism in obese subjects. Rates of turnover, plasma clearance, and expiratory 14CO2 production (indicator of oxidation) after intravenous infusion of a trace amount of [1-14C]-leucine were measured before and one week after starvation (80 cal/day). This dietary treatment caused a significant increase in the rate of 14CO2 production, but significantly reduced the turnover (9.1 versus 7.0 mmole/hr) and plasma clearance (65 versus 34 L/hr) of leucine. When ketosis was prevented by a daily intake of 300 calories of carbohydrate, the rate of 14CO2 production was significantly decreased. On the other hand, starvation-induced decreases in turnover and plasma clearance of leucine, increases in plasma concentrations of branched-chain amino acids (marker for heightened proteolysis), decreases in plasma concentrations of alanine (marker for stimulated hepatic gluconeogenesis), and decreases in plasma concentrations of glucose and insulin were not prevented until carbohydrate intake was increased to 500 or 800 calories per day. Increases in daily carbohydrate intake (up to 500 calories) were accompanied by decreases in urinary excretion of nitrogen, but not 3-methylhistidine (marker for muscle proteolysis). Our data suggest that: (1) ketosis directly or indirectly enhances oxidation of leucine, (2) starvation-induced ketosis, proteolysis, and gluconeogenesis can be prevented sequentially by carbohydrate diets providing fro 300–800 calories per day, (3) the reduced turnover of leucine in starvation is most likely the result of reduced protein synthesis, and (4) diminution of branched-chain amino acid catabolism is a component of the nitrogen-sparing effect of carbohydrate.

View PDFchevron_right
Obese women on a low energy rice and bean diet: effects of leucine, arginine or glycine supplementation on protein turnover
Julio Sergio Marchini

Brazilian Journal of Medical and Biological Research, 2001

This study examined if leucine, arginine or glycine supplementation in adult obese patients (body mass index of 33 ± 4 kg/m 2) consuming a Brazilian low energy and protein diet (4.2 MJ/day and 0.6 g protein/ kg) affects protein and amino acid metabolism. After four weeks adaptation to this diet, each subject received supplements of these amino acids (equivalent to 0.2 g protein kg-1 day-1) in random order. On the seventh day of each amino acid supplementation, a single-dose 15 N-glycine study was carried out. There were no significant differences in protein flux, synthesis or breakdown. The protein flux (grams of nitrogen, gN/9 h) was 55 ± 24 during the nonsupplemented diet intake and 39 ± 10, 44 ± 22 and 58 ± 35 during the leucine-, glycineand arginine-supplemented diet intake, respectively; protein synthesis (gN/9 h) was 57 ± 24, 36 ± 10, 41 ± 22 and 56 ± 36, respectively; protein breakdown (gN/9 h) was 51 ± 24, 34 ± 10, 32 ± 28 and 53 ± 35, respectively; kinetic balance (gN/9 h) was 3.2 ± 1.8, 4.1 ± 1.7, 3.4 ± 2.9 and 3.9 ± 1.6. There was no difference in amino acid profiles due to leucine, arginine or glycine supplementation. The present results suggest that 0.6 g/kg of dietary protein is enough to maintain protein turnover in obese women consuming a reduced energy diet and that leucine, arginine or glycine supplementation does not change kinetic balance or protein synthesis.

View PDFchevron_right
The possible role of leucine in modulating glucose homeostasis under distinct catabolic conditions
Lucas Guimarães Ferreira

Medical hypotheses, 2012

Branched-chain amino acids (BCAA) (especially leucine) have been shown to activate protein synthesis pathways, decrease proteolysis and increase insulin sensitivity. Furthermore, it appears that leucine can be used as a nutritional therapy to avoid sarcopenia and skeletal muscle atrophy due to immobilization or glucocorticoid treatment. However, it is of note that all of these conditions are related to insulin resistance to varying degrees and affect different tissues, particularly skeletal muscle. Additionally, evidence from recent studies demonstrate that a combination of protein containing high levels of leucine with nutrients containing saturated fatty acids or an excess of leucine are capable of inducing insulin resistance. From this discussion, a few major questions arise. First, what is the role of a combination of macronutrients in inducing insulin resistance? Second, in insulin resistance, does leucine supplementation follow the same path observed under healthy conditions? Finally, what are the dose-dependent outcome and the latency of leucine effect under such conditions? The present article discusses these questions based on data from the literature and experiments performed by our group.

View PDFchevron_right
Leucine: Considerations about the Effects of Supplementation
yohannes habte

Journal of Nutrition & Food Sciences, 2014

The main objective of this study is the considerations about the Effects of Leucine Supplementation. Leucine is a branched chain amino acids (BCAA), which is characterized by the ability to be formed from a conformation where an R grouping is non-polar aliphatic. It is noticeable a steady increase in the use of nutritional supplements among physically active, justifying the need of studies to verify the possible benefits and risks that they may lead to health of individuals. In this aspect, this study aimed to highlight the main biochemical and functional characteristics of Leucine. In addition to analyze the possible effects of its supplementation in diets for weight loss on physical performance as well as its benefits to human health, with the largest number of studies that addressed the issue, both in humans and in animals. According to the bibliography found, the Leucine supplementation can influence the protein synthesis, thus contributing to the anabolism, in addition to having an important role in regulating glucose homeostasis aiding weight loss process. Leucine appears as an important supplement for health benefits as an adjunct in the treatment of insulin resistance and may assist in gaining muscle mass in the elderly, as well as contributing to recovery from injuries and wounds in the muscle tissue. It is still necessary more research into the potential health benefits in view that many of the articles analyzed were conducted in animals. It is noteworthy that most of the research conducted tests on animals, highlighting the importance of greater academic literature on this topic. Besides, most relevant studies to conclusions about the effect of intake of leucine in physical performance are also needed, as there are still many disagreements over the results of leucine supplementation on this aspect.

View PDFchevron_right
Dietary protein impact on glycemic control during weight loss
Jamie Baum, Donald Layman

The Journal of nutrition, 2004

Diets with higher protein (1.5 g x kg(-1) x d(-1)) and reduced carbohydrates (120 to 200 g/d) appear to enhance weight loss due to a higher loss of body fat and reduced loss of lean body mass. While studies of prolonged use of moderate protein diets are not available, short-term studies report beneficial effects associated with increased satiety, increased thermogenesis, sparing of muscle protein loss, and enhanced glycemic control. Combined impacts of a moderate protein diet are likely derived from lower carbohydrates resulting in lower postprandial increase in blood glucose and lower insulin response, and higher protein providing increased BCAA leucine levels and gluconeogenic substrates. A key element in the diet appears to be the higher intake of BCAA leucine with unique regulatory actions on muscle protein synthesis, modulation of the insulin signal, and sparing of glucose use by stimulation of the glucose-alanine cycle. This review focuses on the contributions of leucine and t...

View PDFchevron_right
Effects of a leucine-rich diet on body composition during nutritional recovery in rats
Maria Fernanda Mello

Nutrition, 2004

OBJECTIVE: Protein malnutrition is characterized by a number of morphologic and physiologic alterations, including intestinal mucosal atrophy and impaired nutrient absorption. Impaired absorption accentuates nutritional deficiency and accelerates body weight loss and changes in body chemistry. Because leucine is a ketogenic and oxidative amino acid and stimulates the protein synthesis, we examined the ability of young rats to recover from protein malnutrition by feeding them a control balanced or a leucine-rich diet for 60 d. METHODS: At the end of the 60-d period, body, liver, and muscle weights; glucose, methionine, and leucine intestinal absorption; and carcass chemical composition were evaluated. RESULTS: Body weight gain was higher in the control balanced and leucine-rich groups than in control rats, indicating that adequate refeeding allows body weight to recover in these groups. Methionine and glucose absorptions were impaired in malnourished rats but were restored after nutritional recovery. The leucine-rich diet resulted in an increase in carcass collagen nitrogen but maintained the carcass structural nitrogen. CONCLUSIONS: These results indicated that leucine supplementation during nutritional recovery from protein malnutrition improves protein carcass restoration. However, the precise mechanism of the leucine effects involved in this response remains to be elucidated.

View PDFchevron_right

References (64)

  1. Must, A., Spadano, J., Coakley, E. H., Field, A. E., Colditz, G. & Dietz, W. H. (1999) The disease burden associated with overweight and obesity. J. Am. Med. Assoc. 282: 1523-1529.
  2. Surgeon General's Report on Nutrition and Health. (1988) USDHHS Publication no. 88-50210, Public Health Service, Washington, D.C.
  3. American Heart Association: Scientific Statement. (2000) AHA Dietary Guidelines Revison 2000: a statement for healthcare professionals from the Nutrition Committee of the American Heart Association. Circulation 102: 2284 - 2299.
  4. FASEB, Life Sciences Research Office. (1995) Third Report on Nutri- tion Monitoring in the United States. U.S. Government Printing Office, Washing- ton, D.C.
  5. Cahill, G. F. (1970) Starvation in man. N. Engl. J. Med. 282: 668 -675.
  6. Flatt, J. P. (1995) Use and storage of carbohydrate and fat. Am. J. Clin. Nutr. 61(suppl.): 925S.
  7. McGarry, J. D. (1998) Glucose-fatty acid interactions in health and disease. Am. J. Clin. Nutr. 67(suppl.): 500S-504S.
  8. Wolfe, R. R. (1998) Metabolic interactions between glucose and fatty acids in humans. Am. J. Clin. Nutr. 67(suppl.): 519S-526S.
  9. Wolfe, B. M. & Giovannetti, P. M. (1991) Short-term effects of substi- tuting protein for carbohydrate in diets of moderately hypercholesterolemic hu- man subjects. Metabolism 40: 338 -343.
  10. Parker, B., Noakes, M., Luscombe, N. & Clifton, P. (2002) Effect of a high-protein, monounsaturated fat weight loss diet on glycemic control and lipid levels in type 2 diabetes. Diabetes Care 25: 425-430.
  11. Sidossis, L. S., Mittendorfer, B., Walser, E., Chinkes, D. & Wolfe, R. R.
  12. Hyperglycemia-induced inhibition of splanchnic fatty acid oxidation in- creases hepatic triacylglycerol secretion. Am. J. Physiol. Endocrinol. Metab. 275: E798 -E805.
  13. Ludwig, D. S., Majzoub, J. A., Al-Zahrani, A., Dallal, G. E., Blanco, I. & Roberts. S. B. (1999) High glycemic index foods, overeating, and obesity. Pediatrics 103: E261-E266.
  14. Food and Nutrition Board, National Academy of Science. (1994) How Should the Recommended Dietary Allowances Be Revised? National Academy Press, Washington, D.C.
  15. Waterlow, J. C., Garlick, P. J. & Millward, D. J. (1978) Protein Turnover in Mammalian Tissues and in the Whole Body. Elsevier-North Holland, Amster- dam, The Netherlands.
  16. Wolfe, R. R., Wolfe, M. H., Nadel, E. R. & Shaw, J.H.F. (1984) Isotopic determination of amino acid-urea interactions in exercise in humans. J. Appl. Physiol. 56: 221-229.
  17. Hutson, S. M. & Harris, R. A. (2001) Leucine as a nutritional signal. J. Nutr. 131: 839S-840S.
  18. Layman, D. K. (2002) Role of leucine in protein metabolism during exercise and recovery. Can. J. Appl. Physiol. 27(6): 592-608.
  19. Harper, A. E., Miller, R. H. & Block, K. P. (1984) Branched-chain amino acid metabolism. Annu. Rev. Nutr. 4: 409 -454.
  20. Ahlborg, G., Felig, P., Hagenfeldt, L., Hendler, R. & Wahren, J. (1974) Substrate turnover during prolonged exercise in man. J. Clin. Invest. 53: 1080 - 1090.
  21. Ruberman, N. B. (1975) Muscle amino acid metabolism and gluco- neogenesis. Ann. Rev. Med. 26: 245-258.
  22. Patti, M.-E., Brambilla, E., Luzi, L., Landaker, E. J. & Kahn, C. R. (1998) Bidirectional modulation of insulin action by amino acids. J. Clin. Invest. 101: 1519 -1529.
  23. Xu, G., Kwon, G., Marshall, C. A., Lin, T.-A. & Lawrence, J. C. (1998)
  24. Branched-chain amino acids are essential in the regulation of PHAS-I and p70 S6 kinase by pancreatic ␤-cells. J. Biol. Chem. 273: 28178 -28184.
  25. Anthony, J. C., Anthony, T. G., Kimball, S. R. & Jefferson, L. S. (2001) Signaling pathways involved in translational control of protein synthesis in skeletal muscle by leucine. J. Nutr. 131: 856S-860S.
  26. Tischler, M. E., Desautels, M. & Goldberg, A. L. (1982) Does leucine, leucyl-tRNA, or some metabolite of leucine regulate protein synthesis in degra- dation in skeletal and cardiac muscle? J. Biol. Chem. 257: 1613-1621. 25. FAO/WHO/UNU. (1985) Energy and protein requirements. Report of joint FAO/WHO/UNU expert consultation. WHO Tech. Pep. Ser. 724: 1-206.
  27. Anthony, J. C., Yoshizawa, F., Gautsch-Anthony, T., Vary, T. C., Jeffer- son, L. S. & Kimball, S. R. (2000) Leucine stimulates translation initiation in skeletal muscle of postabsorptive rats via a rapamycin-sensitive pathway. J. Nutr. 130: 2413-2419.
  28. El-Khoury, A. E., Kukagawa, N. K., Sanchez, M., Tsay, R. H., Gleason, R. E., Chapman, T. E. & Young, V. R. (1994) The 24-h pattern and rate of leucine oxidation, with particular reference to tracer estimates of leucine require- ments in healthy adults. Am. J. Clin. Nutr. 59: 1012-1020.
  29. Evans, W. J., Fisher, E. C., Hoerr, R. A. & Young, V. R. (1983) Protein metabolism and endurance exercise. Physician Sports Med. 11: 63-72.
  30. Jungas, R. L., Halperin, M. L. & Brosnan, J. T. (1992) Quantitative analysis of amino acid oxidation and related gluconeogenesis in humans. Physiol. Rev. 72: 419 -448.
  31. Katz, J. & Tayek, J. A. (1998) Gluconeogenesis and the Cori cycle in 12-, 20-and 40-h-fasted humans. Am. J. Physiol. Endocrinol. Metab. 38: E537- E542.
  32. Balasubramanyam, A., McKay, S., Nadkarni, P., Rajan, A. S., Farza, A., Pavlik, V., Herd, J. A., Jahoor, F. & Reeds, P. J. (1999) Ethnicity affects the postprandial regulation of glycogenolysis. Am. J. Physiol. Endocrinol. Metab. 40: E905-E914.
  33. Fulks, R. M., Li, J. B. & Goldberg, A. L. (1975) Effects of insulin, glucose, and amino acids on protein turnover in rat diaphragm. J. Biol. Chem. 250: 290 -298.
  34. Li, J. B. & Jefferson, L. S. (1978) Influence of amino acid availability on protein turnover in perfused skeletal muscle. Biochim. Biophys. Acta 544: 351- 359.
  35. Hong, S. C. & Layman, D. K. (1984) Effects of leucine on in vitro protein synthesis and degradation in rat skeletal muscle. J. Nutr. 114: 1204 -1212.
  36. Anthony, J. C., Gautsch-Anthony, T. & Layman, D. K. (1999) Leucine supplementation enhances skeletal muscle recovery in rats following exercise. J. Nutr. 129: 1102-1106.
  37. Tipton, K. D., Ferrando, A. A., Phillips, S. M., Doyle, D. & Wolfe, R. R. (1999) Postexercise net protein synthesis in human muscle from orally admin- istered amino acids. Am. J. Physiol. Endocrinol. Metab. 276: E628 -E634.
  38. Anthony, J. C., Gautsch Anthony, T., Kimball, S. R., Vary, T. C. & Jeffer- son, L. S. (2000) Orally administered leucine stimulates protein synthesis in skeletal muscle of postabsorptive rats in association with increased eIF4F for- mation. J. Nutr. 130: 139 -145.
  39. Gautsch, T. A., Anthony, J. C., Kimball, S. R., Paul, G. L., Layman, D. K.
  40. & Jefferson, L. S. (1998) Availability of eIF4E regulates skeletal muscle protein synthesis during recovery from exercise. Am. J. Physiol. Cell Physiol. 274: C406 - C414.
  41. Anthony, J. C., Anthony, T. G., Kimball, S. R. & Jefferson, L. S. (2001) Signaling pathways involved in translational control of protein synthesis in skeletal muscle by leucine. J. Nutr. 131: 856S-860S.
  42. Food and Nutrition Board. (1989) Recommended Dietary Allowances, 10th ed. National Academy Press, Washington, D.C.
  43. Mayer, J. (1972) Dietary controls of diabetes. In: Human Nutrition: Its Physiological, Medical and Social Aspects, pp. 525-535. Charles C Thomas, Springfield, IL.
  44. Layman, D. K., Boileau, R., Painter, J., Erickson, D., Shiue, H. & Sather, C. (2000) Carbohydrates versus protein in diets for mid-life women. FASEB J. 14: A564 (abs.).
  45. Baum, J., Layman, D., Erickson, D., Boileau, R., Painter, J., Shiue, H. & Sather, C. (2002) Increased dietary protein alters glucose homeostasis during weight loss. FASEB J. 16: A260 (abs.).
  46. Layman, D. K., Shiue, H., Sather, C., Erickson, D. J. & Baum, J. (2003) Increased dietary protein modifies glucose and insulin homeostasis in adult women during weight loss. J. Nutr. (in press).
  47. Layman, D. K., Boileau, R. A., Erickson, D. J., Painter, J. E., Shiue, H., Sather, C. & Christou, D. D. (2003) A reduced ratio of dietary carbohydrate to protein improves body composition and blood lipid profiles during weight loss in adult women. J. Nutr. (in press).
  48. Skov, A. R., Toubro, S., Ronn, B., Holm, L. & Astrup, A. (1999) Ran- domized trial on protein vs carbohydrate in ad libitum fat reduced diet for the treatment of obesity. Int. J. Obes. 23: 528 -536.
  49. Mikkelsen, P. B., Toubro, S. & Astrup. A. (2000) Effect of fat-reduced diets on 24-h energy expenditure: comparisons between animal protein, vegeta- ble protein, and carbohydrate. Am. J. Clin. Nutr. 72: 1135-1141.
  50. Reeds, P. J., Burrin, D. G., Davis, T. A. & Stoll, B. (1998) Amino acid metabolism and the energetics of growth. Arch. Anim. Nutr. 51: 187-197.
  51. Nuttall, F. Q., Mooradian, A. D., Gannon, M. C., Billington, C. J. & Krezowski, P. A. (1984) Effect of protein ingestion on the glucose and insulin response to a standardized oral glucose load. Diabetes Care 7: 465-470.
  52. Ferrannini, E., Bevilacqua, S., Lanzone, L., Bonadonna, R., Brandi, L., Oleggini, M., Boni, C., Buzzigoli, G., Ciociaro, D., Luzi, L. & DeFronzo, R. A. (1988) Metabolic interactions of amino acids and glucose in healthy humans. Diabet. Nutr. Metab. 3: 175-186.
  53. Reaven, G. M. (1993) Role of insulin resistance in human disease (Syndrome X): an expanded definition. Ann. Rev. Med. 44: 121-131.
  54. Kabir, M., Rizkalla, S. W., Quignard-Boulange, A., Guerre-Millo, M., Boil- lot, J., Ardouin, B., Luo, J. & Slama, G. (1998) A high glycemic index starch diet affects lipid storage-related enzymes in normal and to a lesser extent in diabetic rats. J. Nutr. 128: 1878 -1883.
  55. Bistrian, B. R., Winterer, J., Blackburn, G. L., Young, V. & Sherman, M. (1977) Effect of a protein-sparing diet and brief fast on nitrogen metabolism in mildly obese subjects. J. Lab. Clin. Med. 89: 1030 -1035.
  56. Fafournoux, P., Remesy, C. & Demigne, C. (1983) Control of alanine metabolism in rat liver by transport processes or cellular metabolism. Biochem. J. 210: 645-652.
  57. Wagenmakers, A.J.M. (1999) Muscle amino acid metabolism at rest and during exercise: role in human physiology and metabolism. Diabet. Nutr. Metab. 12: 316 -322.
  58. Crapo, P. A., Reaven, G. & Olefsky, J. (1976) Plasma glucose and insulin responses to orally administered simple and complex carbohydrates. Diabetes 25: 741-747.
  59. Shapiro, E. T., Tillil, H., Miller, M. A., Frank, B. H., Galloway, J. A., Rubenstein, A. H. & Polonsky, K. S. (1987) Insulin secretion and clearance: comparison after oral and intravenous glucose. Diabetes 36: 1365-1371.
  60. Poortmans, J. R. & Dellalieux, O. (2000) Do regular high protein diets have potential health risks on kidney function in athletes? Int. J. Sport Nutr. Exerc. Metab. 10: 28 -38.
  61. Brenner, B. M., Meyer, T. W. & Hostetter, T. H. (1982) Dietary protein intake and the progressive nature of kidney disease. N. Engl. J. Med. 307: 652-659.
  62. Addis, T. (1948) Glomerular Nephritis: Diagnosis and Treatment. Mac- millan, New York, NY.
  63. Brandle, E., Sieberth, H. G. & Hautmann, R. E. (1996) Effect of chronic dietary protein intake on the renal function in healthy subjects. Eur. J. Clin. Nutr. 50: 734 -740.
  64. Rudman, D., DiFulco, T. J., Galambos, J. T., Smith, R. B., Salam, A. A. & Warren, W. D. (1973) Maximal rates of excretion and synthesis of urea in normal and cirrhotic subjects. J. Clin. Invest. 52: 2241-2249.

Related papers

Branched-Chain Amino Acids : Metabolism , Physiological Function , and Application Potential Importance of Leucine in Treatment of Obesity and the Metabolic Syndrome 1 – 3
Donald Layman

2005

Diets with total protein intake .1.5 g kg 1 d 1 and carbohydrate intake ,150 g/d are effective for treatment of obesity, type 2 diabetes, and the Metabolic Syndrome. These diets improve body composition and enhance glycemic control. During weight loss, protein-rich diets reduce loss of lean tissue and increase loss of body fat. Specific mechanisms to explain each of these clinical outcomes remain to be fully elucidated. We propose that keys to understanding the relationship between dietary protein and carbohydrates are the relationships between the branched-chain amino acid leucine and insulin and glucose metabolism. Leucine is known to interact with the insulin signaling pathway to stimulate downstream signal control of protein synthesis, resulting in maintenance of muscle protein during periods of restricted energy intake. Leucine also appears to modulate insulin signaling and glucose use by skeletal muscle. Whereas total protein is important in providing substrates for gluconeoge...

View PDFchevron_right
Protein Quantity and Quality at Levels above the RDA Improves Adult Weight Loss
Donald Layman

Journal of The American College of Nutrition, 2004

Evidence is accumulating that diets with reduced carbohydrates and increased levels of high quality protein are effective for weight loss. These diets appear to provide a metabolic advantage during restricted energy intake that targets increased loss of body fat while reducing loss of lean tissue and stabilizing regulations of blood glucose. We have proposed that the branched-chain amino acid leucine is a key to the metabolic advantage of a higher protein diet because of its unique roles in regulation of muscle protein synthesis, insulin signaling and glucose recycling via alanine. These metabolic actions of leucine require plasma and intracellular concentrations to increase above minimum levels maintained by current dietary guidelines and dietary practices in the U.S. Initial findings support use of dietary at levels above 1.5 g/kg ⅐ d during weight loss. Further, our research suggests that increased use of high quality protein at breakfast maybe important for the metabolic advantage of a higher protein diet. Key teaching points: • Methods for nitrogen balance and amino acid oxidation are well suited for defining minimum requirements for essential amino acids but of limited use in understanding optimum amino acid needs for adult health. • Leucine is an essential amino acid with multiple metabolic roles beyond the fundamental use as a substrate for synthesis of new proteins. • Leucine may be a key regulatory amino acid for maintenance of muscle mass during catabolic periods such as weight loss.

View PDFchevron_right
Review Reviewing the Effects of L-Leucine Supplementation in the Regulation of Food Intake, Energy Balance, and
Thais Zampieri

2015

Leucine is a well-known activator of the mammalian target of rapamycin (mTOR). Because mTOR signaling regulates several aspects of metabolism, the potential of leucine as a dietary supplement for treating obesity and diabetes mellitus has been investigated. The objective of the present review was to summarize and discuss the available evidence regarding the mechanisms and the effects of leucine supplementation on the regulation of food intake, energy balance, and glucose homeostasis. Based on the available evidence, we conclude that although central leucine injection decreases food intake, this effect is not well reproduced when leucine is provided as a dietary supplement. Consequently, no robust evidence indicates that oral leucine supplementation significantly affects food intake, although several studies have shown that leucine supplementation may help to decrease body adiposity in specific conditions. However, more studies are necessary to assess the effects of leucine supplementation in already-obese subjects. Finally, although several studies have found that leucine supplementation improves glucose homeostasis, the underlying mechanisms involved in these potential beneficial effects remain unknown and may be partially dependent on weight loss.

View PDFchevron_right
Reviewing the Effects of l-Leucine Supplementation in the Regulation of Food Intake, Energy Balance, and Glucose Homeostasis
Thais Zampieri

Nutrients, 2015

Leucine is a well-known activator of the mammalian target of rapamycin (mTOR). Because mTOR signaling regulates several aspects of metabolism, the potential of leucine as a dietary supplement for treating obesity and diabetes mellitus has been investigated. The objective of the present review was to summarize and discuss the available evidence regarding the mechanisms and the effects of leucine supplementation on the regulation of food intake, energy balance, and glucose homeostasis. Based on the available evidence, we conclude that although central leucine injection decreases food intake, this effect is not well reproduced when leucine is provided as a dietary supplement. Consequently, no robust evidence indicates that oral leucine supplementation significantly affects food intake, although several studies have shown that leucine supplementation may help to decrease body adiposity in specific conditions. However, more studies are necessary to assess the effects of leucine supplementation in already-obese subjects. Finally, although several studies have found that leucine supplementation improves glucose homeostasis, the underlying mechanisms involved in these potential beneficial effects remain unknown and may be partially dependent on weight loss.

View PDFchevron_right
Beyond the role of dietary protein and amino acids in the prevention of diet-induced obesity
Susanne Klaus

International journal of molecular sciences, 2014

High-protein diets have been shown to prevent the development of diet-induced obesity and can improve associated metabolic disorders in mice. Dietary leucine supplementation can partially mimic this effect. However, the molecular mechanisms triggering these preventive effects remain to be satisfactorily explained. Here we review studies showing a connection between high protein or total amino nitrogen intake and obligatory water intake. High amino nitrogen intake may possibly lower lipid storage, and prevent insulin resistance. Suggestions are made for further systematical studies to explore the relationship between water consumption, satiety, and energy expenditure. Moreover, these examinations should better distinguish between leucine-specific and unspecific effects. Research in this field can provide important information to justify dietary recommendations and strategies in promoting long-term weight loss and may help to reduce health problems associated with the comorbidities of...

View PDFchevron_right

Related topics

  • Biochemistry
  • Nutrition and Dietetics
  • Nutrition
  • Biology
  • Medicine
  • Protein Metabolism

    • Cited by

    A whey-protein supplement increases fat loss and spares lean muscle in obese subjects: a randomized human clinical study
    Loren Ward

    Nutrition & Metabolism, 2008

    Background: This study evaluated a specialized whey fraction (Prolibra™, high in leucine, bioactive peptides and milk calcium) for use as a dietary supplement to enhance weight loss.

    View PDFchevron_right
    Effects of beta-hydroxy-beta-methylbutyrate (HMB) on exercise performance and body composition across varying levels of age, sex, and training experience: A review
    Jacob Wilson

    Nutrition & Metabolism, 2008

    The leucine metabolite beta-hydroxy-beta-methylbutyrate (HMB) has been extensively used as an ergogenic aid; particularly among bodybuilders and strength/power athletes, who use it to promote exercise performance and skeletal muscle hypertrophy. While numerous studies have supported the efficacy of HMB in exercise and clinical conditions, there have been a number of conflicting results. Therefore, the first purpose of this paper will be to provide an in depth and objective analysis of HMB research. Special care is taken to present critical details of each study in an attempt to both examine the effectiveness of HMB as well as explain possible reasons for conflicting results seen in the literature. Within this analysis, moderator variables such as age, training experience, various states of muscle catabolism, and optimal dosages of HMB are discussed. The validity of dependent measurements, clustering of data, and a conflict of interest bias will also be analyzed. A second purpose of this paper is to provide a comprehensive discussion on possible mechanisms, which HMB may operate through. Currently, the most readily discussed mechanism has been attributed to HMB as a precursor to the rate limiting enzyme to cholesterol synthesis HMGcoenzyme A reductase. However, an increase in research has been directed towards possible proteolytic pathways HMB may operate through. Evidence from cachectic cancer studies suggests that HMB may inhibit the ubiquitin-proteasome proteolytic pathway responsible for the specific degradation of intracellular proteins. HMB may also directly stimulate protein synthesis, through an mTOR dependent mechanism. Finally, special care has been taken to provide future research implications.

    View PDFchevron_right
    Branched-Chain Amino Acid Database Integrated in MEDIPAD Software as a Tool for Nutritional Investigation of Mediterranean Populations
    Monica Gheorghiu

    Nutrients, 2018

    Branched-chained amino acids (BCAA) are essential dietary components for humans and can act as potential biomarkers for diabetes development. To efficiently estimate dietary intake, we developed a BCAA database for 1331 food items found in the French Centre d'Information sur la Qualité des Aliments (CIQUAL) food table by compiling BCAA content from international tables, published measurements, or by food similarity as well as by calculating 267 items from Greek, Turkish, Romanian, and Moroccan mixed dishes. The database embedded in MEDIPAD software capable of registering 24 h of dietary recalls (24HDR) with clinical and genetic data was evaluated based on archived 24HDR of the Saint Pierre Institute (France) from 2957 subjects, which indicated a BCAA content up to 4.2 g/100 g of food and differences among normal weight and obese subjects across BCAA quartiles. We also evaluated the database of 119 interviews of Romanians, Turkish and Albanians in Greece (27⁻65 years) during the ...

    View PDFchevron_right
    Highly Branched Neo-Fructans (Agavins) Attenuate Metabolic Endotoxemia and Low-Grade Inflammation in Association with Gut Microbiota Modulation on High-Fat Diet-Fed Mice
    Mercedes G. López

    Foods

    Highly branched neo-fructans (agavins) are natural prebiotics found in Agave plants, with a large capacity to mitigate the development of obesity and metabolic syndrome. Here, we investigated the impact of agavins intake on gut microbiota modulation and their metabolites as well as their effect on metabolic endotoxemia and low-grade inflammation in mice fed high-fat diet. Mice were fed with a standard diet (ST) and high-fat diet (HF) alone or plus an agavins supplement (HF+A) for ten weeks. Gut microbiota composition, fecal metabolite profiles, lipopolysaccharides (LPS), pro-inflammatory cytokines, and systemic effects were analyzed. Agavins intake induced substantial changes in gut microbiota composition, enriching Bacteroides, Parabacteroides, Prevotella, Allobaculum, and Akkermansia genus (LDA > 3.0). l-leucine, l-valine, uracil, thymine, and some fatty acids were identified as possible biomarkers for this prebiotic supplement. As novel findings, agavins supplementation signif...

    View PDFchevron_right
    Increased Dietary Leucine Reduces Doxorubicin-Associated Cardiac Dysfunction in Rats
    Simone Deconte

    Frontiers in Physiology, 2018

    Cardiotoxicity is one of the most significant adverse effects of the oncologic treatment with doxorubicin, which is responsible for a substantial morbid and mortality. The occurrence of heart failure with ventricular dysfunction may lead to severe cardiomyopathy and ultimately to death. Studies have focused on the effects of leucine supplementation as a strategy to minimize or revert the clinical condition of induced proteolysis by several clinical onsets. However, the impact of leucine supplementation in heart failure induced by doxorubicin is unknown. Therefore, the objective of this work is to evaluate the effects of leucine supplementation on the cardiotoxicity in the heart of rats treated with doxorubicin. Rats treated with a 7.5 mg/kg cumulative dose of doxorubicin for 14 days presented a dilatation of the left ventricle (LV), and a reduction of the ejection fraction (FE). The 5% supplementation of leucine in the rats' food prevented the malfunctioning of the LV when administered with doxorubicin. Some alterations in the extracellular matrix remodeling were confirmed by the increase of collagen fibers in the doxorubicin group, which did not increase when the treatment was associated with leucine supplementation. Leucine attenuates heart failure in this experimental model with doxorubicin. Such protection is followed by the maintenance of interstitial collagen fibers.

    View PDFchevron_right
    580 California St., Suite 400
    San Francisco, CA, 94104
    © 2025 Academia. All rights reserved